Rebastinib blocks CCM development (IMAGE)

Rockefeller University Press

Rebastinib blocks CCM development

Caption

Microscopic images of cranial blood vessels show the growth of mulberry-shaped CCMs over a 21 day period in control mice (top two rows). This growth is prevented by treatment with the TIE2 inhibitor rebastinib (bottom two rows).

Credit

© 2026 Li et al. Originally published in Journal of Experimental Medicine. https://doi.org/10.1084/jem.20251374

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.